| Identification | Back Directory | [Name]
8-cyclopentyl-6-(1-hydroxyethyl)-5-methyl-2-((5-(piperazin-1-yl)pyridin-2-yl)amino)pyrido[2,3-d]pyrimidin-7(8H)-one | [CAS]
1376615-91-6 | [Synonyms]
Palbociclib-6
Palbociclib Impurity E
Palbociclib Impurity 40
Palbociclib 1-?Hydroxyethyl
8-cyclopentyl-6-(1-hydroxyethyl)-5-methyl-2-((5-(piperazin-1-yl)pyridin-2-yl)amino)pyrido[2,3-d]pyrimidin-7(8H)-one
Palbociclib impurity 29/8-cyclopentyl-6-(1-hydroxyethyl)-5-methyl-2-((5-(piperazin-1-yl)pyridin-2-yl)amino)pyrido[2,3-d]pyrimidin-7(8H)-one
4-[6-(8-Cyclopentyl-5-methyl-7-oxo-6-vinyl-7,8-dihydro-pyrido[2,3-d]pyrimidin-2-ylamino)-pyridin-3-yl]-piperazine-1-carboxylic acid tert-butyl ester | [Molecular Formula]
C24H31N7O2 | [MDL Number]
MFCD32644039 | [MOL File]
1376615-91-6.mol | [Molecular Weight]
449.55 |
| Hazard Information | Back Directory | [Uses]
Palbociclib 1-?Hydroxyethyl is an impurity of Palbociclib(P139900). Palbociclib (also known as compound number PD-0332991) is an experimental drug for the treatment of breast cancer being developed by Pfizer. It is a selective inhibitor of the cyclin-dependent kinases CDK4 and CDK6. |
|
|